세계의 공막염 시장 보고서(2025년)

Scleritis Global Market Report 2025

US $ 4,490 ￦ 6,183,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,938,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,692,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

공막염 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간의 증가는 눈 관련 건강 상태의 유병률 증가, 안구 건강에 대한 인식 증가, 의료비 지출 증가, 안과 연구 확대, 개인 맞춤형 의학에 대한 수요 증가, 그리고 새로운 치료 옵션 개발에 기인할 수 있습니다. 주요 동향으로는 표적 생물학적 요법의 개발, 면역 억제제 제제의 진보, 화상 기술의 혁신, 저침습 진단 툴의 채용, 맞춤형 의료 어프로치의 통합, 약물전달 시스템의 개선, AI 주도의 진단 및 치료 계획 솔루션 등을 들 수 있습니다.

자가면역 질환의 유병률 증가는 공막염 시장의 확대를 촉진할 것으로 예측됩니다. 자가면역 질환의 증가는 유전적 소인, 환경 영향, 라이프 스타일의 변화 및 진단 의식의 향상으로 인한 것입니다. 예를 들어, 2024년 11월 독일에 본사를 둔 조직인 Versorgungsatlas.de는 2022년 보험 가입자 7,324만 1,305명 중 630만 4,340명이 적어도 하나의 자가면역질환으로 진단되었다고 보고했으며, 이는 8.61%의 원병유병률(raw prevalence rate)에 해당한다고 보고했습니다.

공막염 시장의 주요 기업은 염증에 대처하고 비침습적인 치료 옵션을 제공하기 위해 특수 점안약 등의 선진 치료를 개발하고 있습니다. Entod Pharmaceuticals는 인도와 세계에서 CYCLOTEARS 점안약을 출시했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 공막염 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 공막염 시장 : 성장률 분석
• 세계의 공막염 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 공막염 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 공막염 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 공막염 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 정면 공막염
• 후부 공막염
• 기타
• 세계의 공막염 시장 : 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 약
• 수술
• 기타
• 세계의 공막염 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 직접 입찰
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타
• 세계의 공막염 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 전문 클리닉
• 재택 헬스케어
• 기타
• 세계의 공막염 시장 : 전부 공막염별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 비괴사성 정면공막염
• 괴사성 정면 공막염
• 세계의 공막염 시장 : 후부 공막염별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 확산 후부 공막염
• 결절성 후부 공막염
• 공막염 맥락막 병변을 동반하는
• 세계의 공막염 시장 : 그 밖의 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 만성적인 공막염
• 반복 공막염
• 감염성 공막염

제7장 지역별/국가별 분석

• 세계의 공막염 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 공막염 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 공막염 시장 : 경쟁 구도
• 공막염 시장 : 기업 프로파일
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Novartis AG

제31장 기타 주요 기업 및 혁신 기업

• Gilead Sciences Inc.
• Amgen Inc.
• Teva Pharmaceuticals USA Inc.
• Baxter International Inc.
• Boehringer Ingelheim
• Regeneron Pharmaceuticals Inc.
• Fresenius Kabi USA LLC
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company
• Horizon Therapeutics plc
• Aurobindo Pharma Ltd.
• Hikma Pharmaceuticals PLC
• Amneal Pharmaceuticals LLC
• Mallinckrodt Pharmaceuticals
• Alvogen

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 공막염 시장, 2029년 : 새로운 기회를 제공하는 국가
• 공막염 시장, 2029년 : 새로운 기회를 제공하는 부문
• 공막염 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Scleritis is a condition characterized by inflammation of the sclera, the white part of the eye. It is commonly linked to autoimmune diseases and can lead to severe eye pain, redness, and potential vision impairment if left untreated. Proper diagnosis and treatment of scleritis are essential to prevent long-term eye damage. Early medical intervention helps lower the risk of complications, including vision loss.

The primary types of scleritis include anterior scleritis, posterior scleritis, and other forms. Anterior scleritis occurs when the front portion of the sclera, the eye's outer white layer, becomes inflamed, resulting in redness, pain, and swelling around the eyes. Treatment options include medications, surgical procedures, and other therapies. The condition is addressed through various distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and other outlets. Additionally, scleritis treatment is provided in healthcare settings such as hospitals, specialty clinics, home healthcare, and other end-user environments.

The scleritis market research report is one of a series of new reports from The Business Research Company that provides scleritis market statistics, including the scleritis industry's global market size, regional shares, competitors with a scleritis market share, detailed scleritis market segments, market trends and opportunities, and any further data you may need to thrive in the scleritis industry. This scleritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The scleritis market size has grown strongly in recent years. It will grow from $3.60 billion in 2024 to $3.94 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be attributed to the rising prevalence of autoimmune disorders, increased awareness of ocular health, a growing geriatric population, improved access to ophthalmic care, and the expansion of healthcare infrastructure worldwide.

The scleritis market size is expected to see strong growth in the next few years. It will grow to $5.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the increasing prevalence of eye-related health conditions, rising awareness of ocular health, growing healthcare expenditure, expanding ophthalmology research, increasing demand for personalized medicine, and the development of new treatment options. Key trends include the development of targeted biologic therapies, advancements in immunosuppressive drug formulations, innovations in imaging technologies, the adoption of minimally invasive diagnostic tools, the integration of personalized medicine approaches, improvements in drug delivery systems, and AI-driven diagnostic and treatment planning solutions.

The increasing prevalence of autoimmune diseases is expected to drive the expansion of the scleritis market. Autoimmune diseases occur when the body's immune system mistakenly attacks its own healthy cells and tissues, perceiving them as foreign threats. The rise in autoimmune diseases is attributed to genetic predispositions, environmental influences, lifestyle changes, and improved diagnostic awareness. These conditions contribute to scleritis by triggering an inflammatory immune response that mistakenly targets scleral tissue, leading to pain and redness. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that out of 73,241,305 insured individuals in 2022, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Consequently, the growing incidence of autoimmune diseases is fueling the expansion of the scleritis market.

Leading companies in the scleritis market are developing advanced treatments, such as specialized eye drops, to address inflammation and provide non-invasive therapeutic options. Eye drops are liquid formulations designed for direct ocular application to manage conditions such as irritation, dryness, inflammation, and infections. For instance, in May 2023, Entod Pharmaceuticals, an India-based pharmaceutical company, introduced CYCLOTEARS eye drops in India and globally. This innovative treatment for inflammatory eye diseases utilizes proprietary SEDDS technology, enhancing drug delivery and efficacy. The product represents a significant advancement in managing ocular inflammatory conditions, including dry eye disease (DED), ocular myositis, and scleritis.

In January 2025, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, acquired Oxular Limited for an undisclosed amount. This acquisition grants Regeneron access to an advanced ocular gene therapy delivery system, accelerating its progress toward clinical applications. By integrating Oxular's proprietary technologies, Regeneron aims to enhance therapeutic precision and drive innovation in eye care. Oxular Limited, a UK-based biotech company, specializes in developing drug and device treatments for eye disorders, including scleritis.

Major players in the scleritis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceuticals USA Inc., Baxter International Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West-Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Zydus Pharmaceuticals Inc.

North America was the largest region in the scleritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in scleritis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the scleritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The scleritis market consists of revenues earned by entities by providing services such as ultrasound, biologic therapies, and blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The scleritis market includes sales of ophthalmoscopes, nonsteroidal anti-inflammatory drugs, antibiotics, eye shields or patches, and cold or warm compress kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Scleritis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on scleritis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for scleritis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The scleritis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Anterior Scleritis; Posterior Scleritis; Other Types
• 2) By Treatment: Medication; Surgery; Other Treatment
• 3) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channel
• 4) By End-Users: Hospitals; Specialty Clinics; Home Healthcare; Other End-Users
• Subsegments:
• 1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis; Necrotizing Anterior Scleritis
• 2) By Posterior Scleritis: Diffuse Posterior Scleritis; Nodular Posterior Scleritis; Scleritis With Choroidal Involvement
• 3) By Other Types: Chronic Scleritis; Recurrent Scleritis; Infectious Scleritis
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Scleritis Market Characteristics

3. Scleritis Market Trends And Strategies

4. Scleritis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Scleritis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Scleritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Scleritis Market Growth Rate Analysis
• 5.4. Global Scleritis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Scleritis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Scleritis Total Addressable Market (TAM)

6. Scleritis Market Segmentation

• 6.1. Global Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anterior Scleritis
• Posterior Scleritis
• Other Types
• 6.2. Global Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• Other Treatment
• 6.3. Global Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Tender
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channel
• 6.4. Global Scleritis Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Home Healthcare
• Other End-Users
• 6.5. Global Scleritis Market, Sub-Segmentation Of Anterior Scleritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Necrotizing Anterior Scleritis
• Necrotizing Anterior Scleritis
• 6.6. Global Scleritis Market, Sub-Segmentation Of Posterior Scleritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diffuse Posterior Scleritis
• Nodular Posterior Scleritis
• Scleritis With Choroidal Involvement
• 6.7. Global Scleritis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Scleritis
• Recurrent Scleritis
• Infectious Scleritis

7. Scleritis Market Regional And Country Analysis

• 7.1. Global Scleritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Scleritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Scleritis Market

• 8.1. Asia-Pacific Scleritis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Scleritis Market

• 9.1. China Scleritis Market Overview
• 9.2. China Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Scleritis Market

• 10.1. India Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Scleritis Market

• 11.1. Japan Scleritis Market Overview
• 11.2. Japan Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Scleritis Market

• 12.1. Australia Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Scleritis Market

• 13.1. Indonesia Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Scleritis Market

• 14.1. South Korea Scleritis Market Overview
• 14.2. South Korea Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Scleritis Market

• 15.1. Western Europe Scleritis Market Overview
• 15.2. Western Europe Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Scleritis Market

• 16.1. UK Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Scleritis Market

• 17.1. Germany Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Scleritis Market

• 18.1. France Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Scleritis Market

• 19.1. Italy Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Scleritis Market

• 20.1. Spain Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Scleritis Market

• 21.1. Eastern Europe Scleritis Market Overview
• 21.2. Eastern Europe Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Scleritis Market

• 22.1. Russia Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Scleritis Market

• 23.1. North America Scleritis Market Overview
• 23.2. North America Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Scleritis Market

• 24.1. USA Scleritis Market Overview
• 24.2. USA Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Scleritis Market

• 25.1. Canada Scleritis Market Overview
• 25.2. Canada Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Scleritis Market

• 26.1. South America Scleritis Market Overview
• 26.2. South America Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Scleritis Market

• 27.1. Brazil Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Scleritis Market

• 28.1. Middle East Scleritis Market Overview
• 28.2. Middle East Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Scleritis Market

• 29.1. Africa Scleritis Market Overview
• 29.2. Africa Scleritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Scleritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Scleritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Scleritis Market Competitive Landscape And Company Profiles

• 30.1. Scleritis Market Competitive Landscape
• 30.2. Scleritis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Scleritis Market Other Major And Innovative Companies

• 31.1. Gilead Sciences Inc.
• 31.2. Amgen Inc.
• 31.3. Teva Pharmaceuticals USA Inc.
• 31.4. Baxter International Inc.
• 31.5. Boehringer Ingelheim
• 31.6. Regeneron Pharmaceuticals Inc.
• 31.7. Fresenius Kabi USA LLC
• 31.8. Sun Pharmaceutical Industries Ltd.
• 31.9. Perrigo Company
• 31.10. Horizon Therapeutics plc
• 31.11. Aurobindo Pharma Ltd.
• 31.12. Hikma Pharmaceuticals PLC
• 31.13. Amneal Pharmaceuticals LLC
• 31.14. Mallinckrodt Pharmaceuticals
• 31.15. Alvogen

32. Global Scleritis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Scleritis Market

34. Recent Developments In The Scleritis Market

35. Scleritis Market High Potential Countries, Segments and Strategies

• 35.1 Scleritis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Scleritis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Scleritis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료